1-3 of 3
Philip S. Wells
Close
Sort by
Journal Articles

Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism

Clinical Trials & Observations
Philip S. Wells, Tobias Tritschler, Faizan Khan, David R. Anderson, Susan R. Kahn, Alejandro Lazo-Langner, Marc Carrier, Grégoire Le Gal, Lana A. Castellucci, Vinay Shah, Scott Kaatz, Clive Kearon, Susan Solymoss, Russell Zide, Sam Schulman, Isabelle Chagnon, Ranjeeta Mallick, Marc A. Rodger, Michael J. Kovacs
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4605–4616.
https://doi.org/10.1182/bloodadvances.2022007027
Published: 2022
Includes: Supplemental data
Journal Articles

Extended therapy for unprovoked venous thromboembolism: when is it indicated?

Tobias Tritschler, Philip S. Wells
Journal: Blood Advances
Blood Adv (2019) 3 (3): 499.
https://doi.org/10.1182/bloodadvances.2018026518
Published: 2019
Includes: Supplemental data
Journal Articles

Risk of recurrent venous thromboembolism according to baseline risk factor profiles

Clinical Trials & Observations
Martin H. Prins, Anthonie W. A. Lensing, Paolo Prandoni, Philip S. Wells, Peter Verhamme, Jan Beyer-Westendorf, Rupert Bauersachs, Henri Bounameaux, Timothy A. Brighton, Alexander T. Cohen, Bruce L. Davidson, Hervé Decousus, Ajay K. Kakkar, Bonno van Bellen, Akos F. Pap, Martin Homering, Miriam Tamm, Jeffrey I. Weitz
Journal: Blood Advances
Blood Adv (2018) 2 (7): 788–796.
https://doi.org/10.1182/bloodadvances.2018017160
Published: 2018
Includes: Supplemental data